4/15/25

Dr. Jean Talleyrand - The Clinical Endocannabinoid Consortium

Dr. Talleyrand is a pioneer in medical cannabis and is regarded as the most experienced Cannabis Clinician in the world. He shares his involvement in the Emerald Conference and why his cutting edge research from The Dosing project is important.

We also discuss how cannabis is a multi-agent botanical that can affect a wide range of conditions and the need to produce specific products for specific conditions, how alcohol is more socially acceptable than cannabis although alcohol overdose and withdrawal has potentially fatal side effects, nicotine and cannabis use, the need for tolerance breaks, how pharmaceuticals are not taxed nearly as much as cannabis, the need for nationwide laboratory testing standards, cannabis aromatherapy and the discovery phase of terpene profiles….and more

Previous

SJ Labs Interview

Next

Cannabis & Mental Health: Cannabis Media Collective x Dr. Nicole Benton